People
Ricardo Lagoa
Independent Researcher
Email
ricardo.lagoa@ipleiria.pt
Lab
Phone number
-
ORCID
Ciência Vitae
Recent publications
- João Silva; Pavlo Vanat; Dorinda Marques-da-Silva; Joaquim Rui Rodrigues; Ricardo Lagoa. 2020. Metal alginates for polyphenol delivery systems: Studies on crosslinking ions and easy-to-use patches for release of protective flavonoids in skin. Bioactive Materials, 5(3), DOI: 10.1016/j.bioactmat.2020.03.012
- Ricardo Lagoa et al.. 2020. Molecular mechanisms linking environmental toxicants to cancer development: Significance for protective interventions with polyphenols. Elsevier Inc., Academic Press, DOI: 10.1016/j.semcancer.2020.02.002
- Kim, DH; Khan, H; Ullah, H; Hassan, STS; Smejikal, K; Efferth, T; Mahomoodally, MF; Xu, S; Habtemariarn, S; Filosa, R; Lagoa, R; Rengasamy, KR. 2019. MicroRNA targeting by quercetin in cancer treatment and chemoprotection. PHARMACOLOGICAL RESEARCH, 147, DOI: 10.1016/j.phrs.2019.104346
- Dorinda Marques-da-Silva; Gil Fraqueza; Ricardo Lagoa; Anjana Anandan Vannathan; Sib Sankar Mal; Manuel Aureliano. 2019. Polyoxovanadate inhibition of Escherichia coli growth shows a reverse correlation with Ca2+-ATPase inhibition. NEW JOURNAL OF CHEMISTRY, 43(45), DOI: 10.1039/c9nj01208g
- Ricardo Lagoa and Carlos Gutierrez-Merino. 2019. Cytochrome c reducing agents and antiapoptotic action of antioxidants. Cytochrome C: Roles and Therapeutic Implications, Nova Science Publishers, DOI: https://novapublishers.com/shop/cytochrome-c-roles-and-therapeutic-implications/